Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio, World Fusion Create Sequencing Analysis Center

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Japanese informatics management firm World Fusion today announced it has created a sequence analysis service center with a bioinformatics infrastructure based on CLC Bio's enterprise platform for high-throughput sequencing data analysis.

CLC Bio's platform will be coupled with World Fusion's Life Science Knowledge Bank database system. The LSKB database contains annotated information about genes, proteins, compounds, and their structures and literature information.

Terms of the deal were not disclosed.

World Fusion is now also CLC Bio's integration partner in Japan and will assist with the bioinformatics company expansion into that country. In 2009, CLC Bio created a subsidiary in Japan to service the market.

In a statement today, David Leangen, CEO of CLC Bio Japan, said the partnership with World Fusion will help establish CLC Bio "as the leading provider of high-throughput sequencing data analysis software in Japan."

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.